Lithium Can Cause Skin Rashes
Yes, lithium therapy does cause skin rashes and various other dermatologic reactions, which are well-documented adverse effects occurring even at therapeutic serum levels. According to the FDA drug label, lithium causes "generalized pruritus with or without rash" and "cutaneous ulcers" as recognized adverse reactions 1. The dermatologic manifestations are diverse and can significantly impact treatment adherence.
Types of Skin Reactions
The most common cutaneous reactions include:
- Maculopapular rashes - erythematous eruptions that can involve trunk, limbs, and oral mucosa 2
- Acneiform eruptions - occurring in up to 45% of lithium-treated patients in controlled studies 3
- Psoriasis - either new onset or exacerbation of pre-existing disease 4, 3
- Folliculitis - chronic follicular inflammation 1, 3
- Acne inversa (hidradenitis suppurativa) - a rarer but more severe manifestation causing painful nodules and fistulas in skin folds 5
Additional dermatologic effects listed in the FDA label include drying and thinning of hair, skin anesthesia, xerosis cutis, alopecia, and exacerbation of psoriasis 1.
Prevalence and Risk Factors
Controlled studies demonstrate that lithium-treated patients develop significantly more cutaneous reactions than those on other psychotropic medications, with prevalence as high as 45%. 3, 6 Male patients are more susceptible to developing these reactions than females 3, 6.
The mechanism appears related to lithium's tendency to worsen or precipitate conditions characterized by neutrophilic infiltration 3, 6. Importantly, these reactions can occur at therapeutic lithium levels and are not necessarily dose-dependent 4.
Clinical Significance
A documented case with challenge-dechallenge-rechallenge sequence confirmed causality: a patient developed an erythematous maculopapular rash 12 days after starting lithium, which resolved 6 days after discontinuation, then recurred within 24 hours of reintroduction 2. This provides strong evidence for lithium as the causative agent.
Management Approach
Most lithium-related skin reactions can be managed without discontinuing the medication, except in treatment-resistant psoriasis cases. 3, 7
Management strategies include:
- Topical corticosteroids for inflammatory eruptions
- Standard acne treatments (topical retinoids, benzoyl peroxide, antibiotics)
- Dermatology referral for psoriasis management
- Monitoring for secondary bacterial superinfection
- Symptomatic treatment with antihistamines for pruritus
Discontinuation is warranted if:
- Severe psoriasis unresponsive to dermatologic treatment
- Acne inversa develops (resolves with lithium withdrawal) 5
- Patient adherence is compromised due to distressing skin symptoms
Clinical Pitfalls
The FDA label notes these reactions "do not appear to be directly related to serum lithium levels" 1, meaning therapeutic monitoring alone won't prevent dermatologic complications. Clinicians must proactively assess skin at each visit, as these effects can significantly impact medication compliance despite lithium's superior efficacy for bipolar disorder 4, 3.